← Open Payments lookup

MARGARET STUBNER: Open Payments

NPI 1427569714 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,959 in 87 payments from 19 companies in 2025. Trend: 2023 $1,669 · 2024 $1,294 · 2025 $1,959

Food & beverage: $1,959
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$314
Takeda Pharmaceuticals U.S.A., Inc.14$285
Janssen Biotech, Inc.8$278
ABBVIE INC.13$261
GENZYME CORPORATION4$131
Ardelyx, Inc.4$125
Gilead Sciences, Inc.4$99
Madrigal Pharmaceuticals4$94
Regeneron Healthcare Solutions, Inc.3$66
Ipsen Biopharmaceuticals, Inc3$61

Products named: XIFAXAN, TREMFYA, ENTYVIO, DUPIXENT, IBSRELA, REZDIFFRA, RINVOQ, LINZESS.

Industry payments across MD — which companies pay providers there.